National Heart, Lung, and Blood Institutes; Notice of Closed Meeting, 13856 [06-2575]
Download as PDF
<![CDATA[
13856
Federal Register / Vol. 71, No. 52 / Friday, March 17, 2006 / Notices
PMA No./Docket No.
Applicant
P040045/2005M–0504
Vistakon, Division of Johnson &
Johnson Vision Care, Inc.
II. Electronic Access
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Manufacturing Subcommittee of the
Advisory Committee for
Pharmaceutical Science; Cancellation
Food and Drug Administration,
HHS.
Notice.
The Food and Drug
Administration (FDA) is canceling the
meeting of the Manufacturing
Subcommittee of the Advisory
Committee for Pharmaceutical Science
scheduled for April 18 and 19, 2006.
This meeting was announced in the
Federal Register of February 16, 2006
(71 FR 8307).
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Mimi T. Phan, Center for Drug
Evaluation and Research (HFD–21),
Food and Drug Administration, 5600
Fishers Lane (for express delivery, rm.
1093), Rockville, MD 20857, 301–827–
7001, FAX: 301–827–6776, e-mail:
mimi.phan@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138(301–443–0572 in the
Washington, DC area) code 3014512539.
sroberts on PROD1PC70 with NOTICES
Dated: March 10, 2006.
Jason Brodsky,
Acting Associate Commissioner for External
Relations.
[FR Doc. E6–3851 Filed 3–16–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclosed
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Training Programs (T32s and T35s).
Date: May 26, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda, Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Charles Joyce, PhD,
Scientific Review Administrator, Review
Branch, NHLBI, National Institutes of Health,
6701 Rockledge Drive, Room 7196, Bethesda,
MD 20892. 301–435–0288.
cjoyce@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS).
Dated: March 9, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–2575 Filed 3–16–06; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
16:52 Mar 16, 2006
Jkt 208001
December 20, 2005
National Heart, Lung, and Blood
Institutes; Notice of Closed Meeting
BILLING CODE 4160–01–S
BILLING CODE 4160–01–S
VISTAKON (SENOFILCON A)
CONTACT LENS, CLEAR AND
VISIBILITY TINTED WITH UV
BLOCKER
National Institutes of Health
Dated: March 7, 2006.
Linda S. Kahan,
Deputy Director, Center for Devices and
Radiological Health.
[FR Doc. E6–3850 Filed 3–16–06; 8:45 am]
ACTION:
Approval Date
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Persons with access to the Internet
may obtain the documents at https://
www.fda.gov/cdrh/pmapage.html.
AGENCY:
Trade Name
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 06–50, Review FRA DE–06–
005, Orofacial Pain.
Date: April 20, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: H. George Hausch, Ph.D.,
Acting Director, 45 Center Drive, Natcher
Building, Rm. 4AN44F, National Inst. of
Dental & Craniofacial Research, National
Institutes of Health, Bethesda, MD 20892.
(301) 594–2904, george_hausch@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 06–69, Review R21s.
Date: April 24, 2006.
Time: 3:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Lynn M. King, Ph.D.,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., Rm. 4AN–32F,
National Inst. of Dental & Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892–6402. (301) 594–5006,
lynn.king@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 06–59, Review RFA DE–06–
007.
E:\FR\FM\17MRN1.SGM
17MRN1
]]>Agencies
[Federal Register Volume 71, Number 52 (Friday, March 17, 2006)]
[Notices]
[Page 13856]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-2575]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institutes; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Training Programs (T32s and T35s).
Date: May 26, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda, Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Charles Joyce, PhD, Scientific Review
Administrator, Review Branch, NHLBI, National Institutes of Health,
6701 Rockledge Drive, Room 7196, Bethesda, MD 20892. 301-435-0288.
cjoyce@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS).
Dated: March 9, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-2575 Filed 3-16-06; 8:45 am]
BILLING CODE 4140-01-M
